Pfizer CEO Albert Bourla said on Sunday that it is a “likely scenario” that the company’s coronavirus vaccine could be distributed to Americans before the new year if it’s proven by federal regulators to be safe and effective.
“I cannot say what the FDA will do, but I think is a likely scenario and we are preparing for it,” Bourla said in an interview on CBS’ “Face the Nation.” “We started already manufacturing and we have already manufactured hundreds of thousands of doses, so just in case we have a good study readout, conclusive and FDA, plus the advisory committee feels comfortable, that we will be ready.”
Join BJL status for engagements, births, deals, levayos, events & more: bit.ly/32HUBnJ
Join an official BJL WhatsApp group for breaking news as it happens: bit.ly/34zdGuF
Though Bourla said Pfizer's studies show that there's "a good chance that we will know if the product works by the end of October," he noted that distribution before the end of the year ultimately comes down to if and when regulators like the Food and Drug Administration issue a license.
Read more at Fox Business.